The Effects of Resistance Training and Protein Supplementation in Healthy Elderly Men and Women.

The Effects of Resistance Type Exercise Training and Protein Supplementation on Skeletal Muscle Mass, Strength, and Muscle Characteristics in Healthy Elderly Men and Women

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01004588

Enrollment

Registered

2009-10-30

Start date

2009-11-30

Completion date

2012-11-30

Last updated

2015-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Muscle Loss in Elderly

Keywords

elderly, sarcopenia, protein drink, resistance training

Brief summary

The main objective of this study is to examine the effects of resistance type exercise training combined with nutritional support on body composition and muscle characteristics in healthy elderly men and women. For a comprehensive insight into the potential underlying mechanisms of the intervention effects on whole body-, muscle- and myocellular level, a broad range of tests will be performed before, during, and after the intervention period.

Interventions

DIETARY_SUPPLEMENTProtein drink

total of 15 g protein/d in a protein drink consumed every morning after breakfast during 24 weeks

DIETARY_SUPPLEMENTplacebo drink

subjects consume a placebo drink every morning after breakfast over a period of 24 weeks.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

65 Years to 90 Years

Healthy volunteers

Yes

Inclusion criteria

* over 65 years * healthy men and women

Exclusion criteria

* cardiovascular disease * COPD * Parkinson * rheumatoid arthritis * musculoskeletal/orthopaedic disorders * cognitive impairment * subjects with metal implants

Design outcomes

Primary

Measure	Time frame
Change in muscle mass measured by DXA-scan and CT-scan	0, 12 and 24 weeks

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026